These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 30684445)

  • 1. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries.
    Kayssi A; Al-Jundi W; Papia G; Kucey DS; Forbes T; Rajan DK; Neville R; Dueck AD
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012510. PubMed ID: 30684445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs.
    Kayssi A; Al-Atassi T; Oreopoulos G; Roche-Nagle G; Tan KT; Rajan DK
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011319. PubMed ID: 27490003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular brachytherapy for peripheral vascular disease.
    Andras A; Hansrani M; Stewart M; Stansby G
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003504. PubMed ID: 24399686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials.
    Fusaro M; Cassese S; Ndrepepa G; Tepe G; King L; Ott I; Nerad M; Schunkert H; Kastrati A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1284-93. PubMed ID: 24355118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.
    Hsu CC; Kwan GN; Singh D; Rophael JA; Anthony C; van Driel ML
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009195. PubMed ID: 30536919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
    J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial.
    Jongsma H; van Mierlo-van den Broek P; Imani F; van den Heuvel D; de Vries JPM; Fioole B
    J Vasc Surg; 2017 Oct; 66(4):1293-1298. PubMed ID: 28826727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with femoropopliteal arterial occlusive disease.
    Jongsma H; Bekken JA; de Vries JP; Verhagen HJ; Fioole B
    J Vasc Surg; 2016 Nov; 64(5):1503-1514. PubMed ID: 27478005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherectomy for peripheral arterial disease.
    Wardle BG; Ambler GK; Radwan RW; Hinchliffe RJ; Twine CP
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD006680. PubMed ID: 32990327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
    Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial.
    Teichgräber U; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Thieme M; Blessing E; Treitl M; Lichtenberg M; von Flotow P; Vogel B; Werk M; Riambau V; Wienke A; Lehmann T; Sixt S
    Trials; 2016 Oct; 17(1):528. PubMed ID: 27793175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial.
    Fanelli F; Cannavale A; Boatta E; Corona M; Lucatelli P; Wlderk A; Cirelli C; Salvatori FM
    J Endovasc Ther; 2012 Oct; 19(5):571-80. PubMed ID: 23046320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-coated versus uncoated balloon angioplasty for femoropopliteal artery in-stent restenosis.
    Wu R; Li Z; Wang M; Chang G; Yao C; Wang S
    Int J Surg; 2017 Jun; 42():72-82. PubMed ID: 28461145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial.
    Karimi A; de Boer SW; van den Heuvel DA; Fioole B; Vroegindeweij D; Heyligers JM; Lohle PN; Elgersma O; Nolthenius RP; Vos JA; de Vries JP
    Trials; 2013 Mar; 14():87. PubMed ID: 23537403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Randomized Freeway Stent Study: Drug-Eluting Balloons Outperform Standard Balloon Angioplasty for Postdilatation of Nitinol Stents in the SFA and PI Segment.
    Tacke J; Müller-Hülsbeck S; Schröder H; Lammer J; Schürmann K; Gross-Fengels W; Fischbach R; Textor J; Boguth L; Loewe C; Häuser H; Gschwendtner M; Tepe G; von Strandmann RP; Stahnke S; Dambach J; Hausegger K
    Cardiovasc Intervent Radiol; 2019 Nov; 42(11):1513-1521. PubMed ID: 31432220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angioplasty versus stenting for iliac artery lesions.
    Jongsma H; Bekken J; Ayez N; Hoogewerf CJ; Van Weel V; Fioole B
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007561. PubMed ID: 33258499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.